New Delhi, October 23, 2026: Sakar Healthcare on Friday reported a consolidated net profit of Rs 11.30 crore for the September quarter, up from Rs 4.54 crore in the year-ago period.
Its revenue from operations rose 51.9 per cent to Rs 87.41 crore during the quarter, compared with Rs 57.56 crore a year earlier, according to a regulatory filing.
Oncology Business Drives Growth
The company said growth in the second quarter was supported by new oncology approvals, strong demand across geographies, a better oncology mix, operating leverage and disciplined cost management.
Also Watch:
Sakar Healthcare Managing Director Sanjay Shah said, “Q2 has been a quarter of meaningful progress for our oncology business, with encouraging developments across regulatory approvals, technology transfers and global market access.”
(Disclaimer: Except for the headline, this article has not been edited by FPJ's editorial team and is auto-generated from an agency feed.)
